{"protocolSection":{"identificationModule":{"nctId":"NCT01327612","orgStudyIdInfo":{"id":"20101116"},"secondaryIdInfos":[{"id":"2010-022270-14","type":"EUDRACT_NUMBER"}],"organization":{"fullName":"Amgen","class":"INDUSTRY"},"briefTitle":"Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)","officialTitle":"A Phase 2 Open Label Extension Study of Conatumumab and AMG 479"},"statusModule":{"statusVerifiedDate":"2021-02","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2011-03-03","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2020-02-05","type":"ACTUAL"},"completionDateStruct":{"date":"2020-02-05","type":"ACTUAL"},"studyFirstSubmitDate":"2011-03-03","studyFirstSubmitQcDate":"2011-03-31","studyFirstPostDateStruct":{"date":"2011-04-01","type":"ESTIMATED"},"resultsFirstSubmitDate":"2021-02-03","resultsFirstSubmitQcDate":"2021-02-03","resultsFirstPostDateStruct":{"date":"2021-02-21","type":"ACTUAL"},"lastUpdateSubmitDate":"2021-02-03","lastUpdatePostDateStruct":{"date":"2021-02-21","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Amgen","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The purpose of this protocol is to allow continued treatment with conatumumab and/or ganitumab, with or without chemotherapy, to participants who completed a separate Amgen-sponsored conatumumab or ganitumab study without disease progression whose previous studies were closed."},"conditionsModule":{"conditions":["Advanced Solid Tumors","Carcinoid","Colorectal Cancer","Locally Advanced","Lymphoma","Metastatic Cancer","Non-Small Cell Lung Cancer","Sarcoma","Solid Tumors"],"keywords":["AMG 655","AMG 479","Apoptosis","Monoclonal Antibody","Tumor Necrosis Factor","Insulin-like Growth Factor","Bevacizumab","Modified FOLFOX6","mFOLFOX6","FOLFOX","Lymphoma","Trail Receptor","ganitumab","conatumumab"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":12,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Conatumumab Monotherapy","type":"EXPERIMENTAL","description":"Participants will continue to receive conatumumab every 2 weeks (Q2W) or every 3 weeks (Q3W) at the same dose and regimen as at the conclusion of the parent study.","interventionNames":["Biological: Conatumumab"]},{"label":"Conatumumab + Ganitumab","type":"EXPERIMENTAL","description":"Participants will receive conatumumab and ganitumab by intravenous infusion at the same dose and regimen as at the conclusion of the parent study.","interventionNames":["Biological: Conatumumab","Biological: Ganitumab"]},{"label":"Ganitumab Monotherapy","type":"EXPERIMENTAL","description":"Participants will continue to receive ganitumab Q3W or every 4 weeks (Q4W) at the same dose and regimen as at the conclusion of the parent study.","interventionNames":["Biological: Ganitumab"]},{"label":"Conatumumab + mFOLFOX6 ± Bevacizumab","type":"EXPERIMENTAL","description":"Participants will continue to receive conatumumab by intravenous infusion in addition to modified FOLFOX6 chemotherapy with or without bevacizumab.","interventionNames":["Drug: Modified FOLFOX6","Biological: Conatumumab","Biological: Bevacizumab"]}],"interventions":[{"type":"DRUG","name":"Modified FOLFOX6","description":"The mFOLFOX6 regimen is a combination therapy of oxaliplatin 85 mg/m² administered as a 2-hour intravenous (IV) infusion on day 1 and leucovorin 400 mg/m² racemate or 200 mg/m² levo-leucovorin administered as a 2-hour infusion on day 1, followed by a loading dose of 5-fluorouracil (5-FU) 400 mg/m² IV bolus administered on day 1, then 5-FU 2400 mg/m² via ambulatory pump administered for a period of 46 to 48 hours every 14 days.","armGroupLabels":["Conatumumab + mFOLFOX6 ± Bevacizumab"],"otherNames":["Oxaliplatin-Leucovorin-Fluorouracil chemotherapy"]},{"type":"BIOLOGICAL","name":"Conatumumab","description":"Administered by intravenous infusion Q2W or Q3W.","armGroupLabels":["Conatumumab + Ganitumab","Conatumumab + mFOLFOX6 ± Bevacizumab","Conatumumab Monotherapy"],"otherNames":["AMG 655"]},{"type":"BIOLOGICAL","name":"Ganitumab","description":"Administered by intravenous infusion Q3W or Q4W.","armGroupLabels":["Conatumumab + Ganitumab","Ganitumab Monotherapy"],"otherNames":["AMG 479"]},{"type":"BIOLOGICAL","name":"Bevacizumab","description":"Administered at a dose of 5 mg/kg by intravenous infusion on day 1 of each 14 day cycle.","armGroupLabels":["Conatumumab + mFOLFOX6 ± Bevacizumab"],"otherNames":["Avastin"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Participants With Adverse Events","description":"An adverse event is defined as any untoward medical occurrence in a clinical trial participant, including worsening of a pre-existing medical condition. The event does not necessarily have a causal relationship with study treatment.","timeFrame":"From first dose of study drug in the extension study to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab."},{"measure":"Number of Participants With Serious Adverse Events","description":"A serious adverse event is defined as an adverse event that met at least 1 of the following serious criteria:\n\n* fatal,\n* life threatening (places the participant at immediate risk of death),\n* required in-patient hospitalization or prolongation of existing hospitalization,\n* resulted in persistent or significant disability/incapacity,\n* congenital anomaly/birth defect, and/or\n* other medically important serious event.","timeFrame":"From first dose of study drug in the extension study to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab."}],"secondaryOutcomes":[{"measure":"Maximum Change From Baseline in Blood Pressure","description":"Maximum change from baseline is defined for each participant as the maximum change from baseline value observed across all visits.","timeFrame":"Baseline and day 1 of each treatment cycle (every 2, 3, or 4 weeks depending on dosing schedule) up to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab."},{"measure":"Minimum Change From Baseline in Blood Pressure","description":"Minimum change from baseline is defined for each participant as the minimum change from baseline value observed across all visits.","timeFrame":"Baseline and day 1 of each treatment cycle (every 2, 3, or 4 weeks depending on dosing schedule) up to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab."},{"measure":"Number of Participants With CTCAE Grade 3 or Higher Clinical Laboratory Toxicities","description":"Laboratory toxicities were graded according to the Common Terminology Criteria for Adverse Events (CTCAE) version 3.0.","timeFrame":"From first dose of study drug in the extension study to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab."},{"measure":"Best Overall Response","description":"Radiological assessments to evaluate disease extent (with change compared to nadir from the parent protocol) were performed at regular intervals, at a minimum once every 6 months or more frequently if clinically indicated (starting from their last scan on the parent protocol), per standard of care (SOC) at each facility. Tumor response was assessed by the Investigator as either complete response, partial response, stable disease, or progressive disease.","timeFrame":"Approximately every 6 months until end of treatment; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab."},{"measure":"Number of Participants With Disease Progression or Death Due to Disease Progression","timeFrame":"From first dose of study drug in the extension study to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* To be enrolled in this study, subjects must be currently enrolled in a prior Amgen-sponsored conatumumab or AMG 479 study and are eligible according to the parent study to receive their next dose of conatumumab (with or without co-therapy), or AMG 479 alone.\n\nSubjects must have their eligibility assessed for this study and be enrolled within 30 days of their last treatment on the parent protocol\n\nExclusion Criteria:\n\n* Discontinued from a conatumumab study due to an adverse event considered by the investigator to be related to conatumumab treatment, including intolerance to conatumumab\n* Subjects determined to have disease progression during their participation in the parent Amgen study\n* Woman or man with partner of childbearing potential not consenting to use adequate contraceptive precautions ie, double barrier contraceptive methods (eg, diaphragm plus condom), or abstinence during the course of the study and for 6 months after the last dose of protocol-specified therapy administration\n* Subject is pregnant or breast feeding, or planning to become pregnant within 6 months after the last dose of protocol-specified therapy administration\n* Male subject with a pregnant partner who is not willing to use a condom during treatment and for an additional 6 months after the last dose of protocol-specified therapy administration\n* Subject has previously entered this study\n* Subject will not be available for protocol required study visits, to the best of the subject and investigator's knowledge\n* Subject has any kind of disorder that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent and/or to comply with all required study procedures","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"MD","affiliation":"Amgen","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Research Site","city":"Duarte","state":"California","zip":"91010","country":"United States","geoPoint":{"lat":34.13945,"lon":-117.97729}},{"facility":"Research Site","city":"La Jolla","state":"California","zip":"92093-0957","country":"United States","geoPoint":{"lat":32.84727,"lon":-117.2742}},{"facility":"Research Site","city":"Denver","state":"Colorado","zip":"80218","country":"United States","geoPoint":{"lat":39.73915,"lon":-104.9847}},{"facility":"Research Site","city":"Tampa","state":"Florida","zip":"33612","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"Research Site","city":"Ann Arbor","state":"Michigan","zip":"48109","country":"United States","geoPoint":{"lat":42.27756,"lon":-83.74088}},{"facility":"Research Site","city":"Buffalo","state":"New York","zip":"14263","country":"United States","geoPoint":{"lat":42.88645,"lon":-78.87837}},{"facility":"Research Site","city":"Memphis","state":"Tennessee","zip":"38120","country":"United States","geoPoint":{"lat":35.14953,"lon":-90.04898}},{"facility":"Research Site","city":"Houston","state":"Texas","zip":"77030","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Research Site","city":"San Antonio","state":"Texas","zip":"78229","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"Research Site","city":"Ogden","state":"Utah","zip":"84403","country":"United States","geoPoint":{"lat":41.223,"lon":-111.97383}},{"facility":"Research Site","city":"Szczecin","zip":"70-891","country":"Poland","geoPoint":{"lat":53.42894,"lon":14.55302}},{"facility":"Research Site","city":"Barcelona","state":"Catalonia","zip":"08035","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}}]},"referencesModule":{"seeAlsoLinks":[{"label":"AmgenTrials clinical trials website","url":"http://www.amgentrials.com"}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request","infoTypes":["STUDY_PROTOCOL","SAP","ICF","CSR"],"timeFrame":"Data sharing requests relating to this study will be considered beginning 18 months after the study has ended and either 1) the product and indication (or other new use) have been granted marketing authorization in both the US and Europe or 2) clinical development for the product and/or indication discontinues and the data will not be submitted to regulatory authorities. There is no end date for eligibility to submit a data sharing request for this study.","accessCriteria":"Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen study/studies in scope, endpoints/outcomes of interest, statistical analysis plan, data requirements, publication plan, and qualifications of the researcher(s). In general, Amgen does not grant external requests for individual patient data for the purpose of re-evaluating safety and efficacy issues already addressed in the product labelling. Requests are reviewed by a committee of internal advisors, and if not approved, may be further arbitrated by a Data Sharing Independent Review Panel. Upon approval, information necessary to address the research question will be provided under the terms of a data sharing agreement. This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code where provided in analysis specifications. Further details are available at the URL below.","url":"https://www.amgen.com/datasharing"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"This was an extension study that permitted participants to continue treatment with conatumumab, with or without co-therapy (modified FOLFOX6 chemotherapy with or without bevacizumab, or ganitumab), or with ganitumab alone, administered at the same dose level and schedule that participants received at the conclusion of the parent study. Participants remained on treatment until disease progression, intolerability, or withdrawal of consent.\n\nResults are reported by parent study and treatment.","recruitmentDetails":"This study enrolled participants with different types of solid tumors who had completed one of the following Amgen-sponsored conatumumab or ganitumab studies:\n\n20050118 (NCT00562380) 20050171 20060295 (NCT00534027) 20060340 (NCT00791011) 20060464 (NCT00625651) 20070411 (NCT00819169). Participants who had not progressed in the parent study were eligible to participate in this trial.\n\nThe study was conducted at 12 centers in the United States, Spain, and Poland.","groups":[{"id":"FG000","title":"20050118: Ganitumab 20 mg/kg","description":"Ganitumab 20 mg/kg once every 4 weeks by intravenous infusion."},{"id":"FG001","title":"20050171: Conatumumab 0.45 mg/kg","description":"Conatumumab 0.45 mg/kg every 2 weeks by intravenous infusion."},{"id":"FG002","title":"20060295: Conatumumab 3 mg/kg","description":"Conatumumab 3 mg/kg every 3 weeks by intravenous infusion."},{"id":"FG003","title":"20060340: Conatumumab 5 mg/kg","description":"Conatumumab 5 mg/kg once every 3 weeks by intravenous infusion."},{"id":"FG004","title":"20060464: Conatumumab 2 mg/kg + mFOLFOX6 + Bevacizumab","description":"Conatumumab 2 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 (mFOLFOX6) chemotherapy and bevacizumab 5 mg/kg once every 2 weeks."},{"id":"FG005","title":"20060464: Conatumumab 10 mg/kg + mFOLFOX6 ± Bevacizumab","description":"Conatumumab 10 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy, with or without bevacizumab 5 mg/kg once every 2 weeks."},{"id":"FG006","title":"20070411: Conatumumab 15 mg/kg + Ganitumab 18 mg/kg","description":"Conatumumab 15 mg/kg + ganitumab 18 mg/kg once every 3 weeks by intravenous infusion."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"2"},{"groupId":"FG005","numSubjects":"3"},{"groupId":"FG006","numSubjects":"2"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"2"},{"groupId":"FG005","numSubjects":"3"},{"groupId":"FG006","numSubjects":"2"}]}],"dropWithdraws":[{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"0"}]},{"type":"Disease Progression","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"2"},{"groupId":"FG006","numSubjects":"2"}]},{"type":"Administrative Decision","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"}]},{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"Participants who received at least one dose of conatumumab or ganitumab.","groups":[{"id":"BG000","title":"20050118: Ganitumab 20 mg/kg","description":"Ganitumab 20 mg/kg once every 4 weeks by intravenous infusion."},{"id":"BG001","title":"20050171: Conatumumab 0.45 mg/kg","description":"Conatumumab 0.45 mg/kg every 2 weeks by intravenous infusion."},{"id":"BG002","title":"20060295: Conatumumab 3 mg/kg","description":"Conatumumab 3 mg/kg every 3 weeks by intravenous infusion."},{"id":"BG003","title":"20060340: Conatumumab 5 mg/kg","description":"Conatumumab 5 mg/kg once every 3 weeks by intravenous infusion."},{"id":"BG004","title":"20060464: Conatumumab 2 mg/kg + mFOLFOX6 + Bevacizumab","description":"Conatumumab 2 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy and bevacizumab 5 mg/kg once every 2 weeks."},{"id":"BG005","title":"20060464: Conatumumab 10 mg/kg + mFOLFOX6 ± Bevacizumab","description":"Conatumumab 10 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy, with or without bevacizumab 5 mg/kg once every 2 weeks."},{"id":"BG006","title":"20070411: Conatumumab 15 mg/kg + Ganitumab 18 mg/kg","description":"Conatumumab 15 mg/kg + ganitumab 18 mg/kg once every 3 weeks by intravenous infusion."},{"id":"BG007","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"2"},{"groupId":"BG005","value":"3"},{"groupId":"BG006","value":"2"},{"groupId":"BG007","value":"12"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"60.0","spread":"14.1"},{"groupId":"BG001","value":"57.0"},{"groupId":"BG002","value":"44.0"},{"groupId":"BG003","value":"46.0"},{"groupId":"BG004","value":"66.5","spread":"7.8"},{"groupId":"BG005","value":"56.3","spread":"8.7"},{"groupId":"BG006","value":"68.0","spread":"15.6"},{"groupId":"BG007","value":"58.8","spread":"11.1"}]}]}]},{"title":"Age, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"18 - 64 years","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"8"}]},{"title":"65 - 74 years","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"3"}]},{"title":"75 - 84 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"1"}]},{"title":"≥ 85 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"5"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"7"}]}]}]},{"title":"Ethnicity (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"2"},{"groupId":"BG005","value":"3"},{"groupId":"BG006","value":"2"},{"groupId":"BG007","value":"12"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"1"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"1"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"2"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"2"},{"groupId":"BG007","value":"10"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Adverse Events","description":"An adverse event is defined as any untoward medical occurrence in a clinical trial participant, including worsening of a pre-existing medical condition. The event does not necessarily have a causal relationship with study treatment.","populationDescription":"Participants who received at least one dose of conatumumab or ganitumab.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From first dose of study drug in the extension study to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab.","groups":[{"id":"OG000","title":"20050118: Ganitumab 20 mg/kg","description":"Ganitumab 20 mg/kg once every 4 weeks by intravenous infusion."},{"id":"OG001","title":"20050171: Conatumumab 0.45 mg/kg","description":"Conatumumab 0.45 mg/kg every 2 weeks by intravenous infusion."},{"id":"OG002","title":"20060295: Conatumumab 3 mg/kg","description":"Conatumumab 3 mg/kg every 3 weeks by intravenous infusion."},{"id":"OG003","title":"20060340: Conatumumab 5 mg/kg","description":"Conatumumab 5 mg/kg once every 3 weeks by intravenous infusion."},{"id":"OG004","title":"20060464: Conatumumab 2 mg/kg + mFOLFOX6 + Bevacizumab","description":"Conatumumab 2 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy and bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG005","title":"20060464: Conatumumab 10 mg/kg + mFOLFOX6 ± Bevacizumab","description":"Conatumumab 10 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy, with or without bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG006","title":"20070411: Conatumumab 15 mg/kg + Ganitumab 18 mg/kg","description":"Conatumumab 15 mg/kg + ganitumab 18 mg/kg once every 3 weeks by intravenous infusion."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Serious Adverse Events","description":"A serious adverse event is defined as an adverse event that met at least 1 of the following serious criteria:\n\n* fatal,\n* life threatening (places the participant at immediate risk of death),\n* required in-patient hospitalization or prolongation of existing hospitalization,\n* resulted in persistent or significant disability/incapacity,\n* congenital anomaly/birth defect, and/or\n* other medically important serious event.","populationDescription":"Participants who received at least one dose of conatumumab or ganitumab.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From first dose of study drug in the extension study to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab.","groups":[{"id":"OG000","title":"20050118: Ganitumab 20 mg/kg","description":"Ganitumab 20 mg/kg once every 4 weeks by intravenous infusion."},{"id":"OG001","title":"20050171: Conatumumab 0.45 mg/kg","description":"Conatumumab 0.45 mg/kg every 2 weeks by intravenous infusion."},{"id":"OG002","title":"20060295: Conatumumab 3 mg/kg","description":"Conatumumab 3 mg/kg every 3 weeks by intravenous infusion."},{"id":"OG003","title":"20060340: Conatumumab 5 mg/kg","description":"Conatumumab 5 mg/kg once every 3 weeks by intravenous infusion."},{"id":"OG004","title":"20060464: Conatumumab 2 mg/kg + mFOLFOX6 + Bevacizumab","description":"Conatumumab 2 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy and bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG005","title":"20060464: Conatumumab 10 mg/kg + mFOLFOX6 ± Bevacizumab","description":"Conatumumab 10 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy, with or without bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG006","title":"20070411: Conatumumab 15 mg/kg + Ganitumab 18 mg/kg","description":"Conatumumab 15 mg/kg and ganitumab 18 mg/kg once every 3 weeks by intravenous infusion."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"}]}]}]},{"type":"SECONDARY","title":"Maximum Change From Baseline in Blood Pressure","description":"Maximum change from baseline is defined for each participant as the maximum change from baseline value observed across all visits.","populationDescription":"Participants who received at least one dose of conatumumab or ganitumab.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"mmHg","timeFrame":"Baseline and day 1 of each treatment cycle (every 2, 3, or 4 weeks depending on dosing schedule) up to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab.","groups":[{"id":"OG000","title":"20050118: Ganitumab 20 mg/kg","description":"Ganitumab 20 mg/kg once every 4 weeks by intravenous infusion."},{"id":"OG001","title":"20050171: Conatumumab 0.45 mg/kg","description":"Conatumumab 0.45 mg/kg every 2 weeks by intravenous infusion."},{"id":"OG002","title":"20060295: Conatumumab 3 mg/kg","description":"Conatumumab 3 mg/kg every 3 weeks by intravenous infusion."},{"id":"OG003","title":"20060340: Conatumumab 5 mg/kg","description":"Conatumumab 5 mg/kg once every 3 weeks by intravenous infusion."},{"id":"OG004","title":"20060464: Conatumumab 2 mg/kg + mFOLFOX6 + Bevacizumab","description":"Conatumumab 2 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy and bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG005","title":"20060464: Conatumumab 10 mg/kg + mFOLFOX6 ± Bevacizumab","description":"Conatumumab 10 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy, with or without bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG006","title":"20070411: Conatumumab 15 mg/kg + Ganitumab 18 mg/kg","description":"Conatumumab 15 mg/kg + ganitumab 18 mg/kg once every 3 weeks by intravenous infusion."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"}]}],"classes":[{"title":"Systolic blood pressure","categories":[{"measurements":[{"groupId":"OG000","value":"5.5","spread":"9.2"},{"groupId":"OG001","value":"7.0"},{"groupId":"OG002","value":"54.0"},{"groupId":"OG003","value":"37.0"},{"groupId":"OG004","value":"42.0","spread":"0.0"},{"groupId":"OG005","value":"26.0","spread":"17.3"},{"groupId":"OG006","value":"32.5","spread":"31.8"}]}]},{"title":"Diastolic blood pressure","categories":[{"measurements":[{"groupId":"OG000","value":"7.5","spread":"9.2"},{"groupId":"OG001","value":"1.0"},{"groupId":"OG002","value":"10.0"},{"groupId":"OG003","value":"13.0"},{"groupId":"OG004","value":"27.5","spread":"9.2"},{"groupId":"OG005","value":"14.7","spread":"6.4"},{"groupId":"OG006","value":"23.5","spread":"6.4"}]}]}]},{"type":"SECONDARY","title":"Minimum Change From Baseline in Blood Pressure","description":"Minimum change from baseline is defined for each participant as the minimum change from baseline value observed across all visits.","populationDescription":"Participants who received at least one dose of conatumumab or ganitumab.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"mmHg","timeFrame":"Baseline and day 1 of each treatment cycle (every 2, 3, or 4 weeks depending on dosing schedule) up to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab.","groups":[{"id":"OG000","title":"20050118: Ganitumab 20 mg/kg","description":"Ganitumab 20 mg/kg once every 4 weeks by intravenous infusion."},{"id":"OG001","title":"20050171: Conatumumab 0.45 mg/kg","description":"Conatumumab 0.45 mg/kg every 2 weeks by intravenous infusion."},{"id":"OG002","title":"20060295: Conatumumab 3 mg/kg","description":"Conatumumab 3 mg/kg every 3 weeks by intravenous infusion."},{"id":"OG003","title":"20060340: Conatumumab 5 mg/kg","description":"Conatumumab 5 mg/kg once every 3 weeks by intravenous infusion."},{"id":"OG004","title":"20060464: Conatumumab 2 mg/kg + mFOLFOX6 + Bevacizumab","description":"Conatumumab 2 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy and bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG005","title":"20060464: Conatumumab 10 mg/kg + mFOLFOX6 ± Bevacizumab","description":"Conatumumab 10 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy, with or without bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG006","title":"20070411: Conatumumab 15 mg/kg + Ganitumab 18 mg/kg","description":"Conatumumab 15 mg/kg + ganitumab 18 mg/kg once every 3 weeks by intravenous infusion."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"}]}],"classes":[{"title":"Systolic blood pressure","categories":[{"measurements":[{"groupId":"OG000","value":"-28.5","spread":"17.7"},{"groupId":"OG001","value":"-45.0"},{"groupId":"OG002","value":"-20.0"},{"groupId":"OG003","value":"-21.0"},{"groupId":"OG004","value":"-22.5","spread":"16.3"},{"groupId":"OG005","value":"-29.0","spread":"10.8"},{"groupId":"OG006","value":"-12.0","spread":"12."}]}]},{"title":"Diastolic blood pressure","categories":[{"measurements":[{"groupId":"OG000","value":"-19.5","spread":"9.2"},{"groupId":"OG001","value":"-27.0"},{"groupId":"OG002","value":"-20.0"},{"groupId":"OG003","value":"-25.0"},{"groupId":"OG004","value":"-8.5","spread":"7.8"},{"groupId":"OG005","value":"-14.3","spread":"5.5"},{"groupId":"OG006","value":"-10.0","spread":"4.2"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With CTCAE Grade 3 or Higher Clinical Laboratory Toxicities","description":"Laboratory toxicities were graded according to the Common Terminology Criteria for Adverse Events (CTCAE) version 3.0.","populationDescription":"Participants who received at least one dose of conatumumab or ganitumab.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From first dose of study drug in the extension study to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab.","groups":[{"id":"OG000","title":"20050118: Ganitumab 20 mg/kg","description":"Ganitumab 20 mg/kg once every 4 weeks by intravenous infusion."},{"id":"OG001","title":"20050171: Conatumumab 0.45 mg/kg","description":"Conatumumab 0.45 mg/kg every 2 weeks by intravenous infusion."},{"id":"OG002","title":"20060295: Conatumumab 3 mg/kg","description":"Conatumumab 3 mg/kg every 3 weeks by intravenous infusion."},{"id":"OG003","title":"20060340: Conatumumab 5 mg/kg","description":"Conatumumab 5 mg/kg once every 3 weeks by intravenous infusion."},{"id":"OG004","title":"20060464: Conatumumab 2 mg/kg + mFOLFOX6 + Bevacizumab","description":"Conatumumab 2 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy and bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG005","title":"20060464: Conatumumab 10 mg/kg + mFOLFOX6 ± Bevacizumab","description":"Conatumumab 10 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy, with or without bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG006","title":"20070411: Conatumumab 15 mg/kg + Ganitumab 18 mg/kg","description":"Conatumumab 15 mg/kg + ganitumab 18 mg/kg once every 3 weeks by intravenous infusion."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"2"},{"groupId":"OG006","value":"1"}]}]}]},{"type":"SECONDARY","title":"Best Overall Response","description":"Radiological assessments to evaluate disease extent (with change compared to nadir from the parent protocol) were performed at regular intervals, at a minimum once every 6 months or more frequently if clinically indicated (starting from their last scan on the parent protocol), per standard of care (SOC) at each facility. Tumor response was assessed by the Investigator as either complete response, partial response, stable disease, or progressive disease.","populationDescription":"Participants who received at least one dose of conatumumab or ganitumab.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Approximately every 6 months until end of treatment; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab.","groups":[{"id":"OG000","title":"20050118: Ganitumab 20 mg/kg","description":"Ganitumab 20 mg/kg once every 4 weeks by intravenous infusion."},{"id":"OG001","title":"20050171: Conatumumab 0.45 mg/kg","description":"Conatumumab 0.45 mg/kg every 2 weeks by intravenous infusion."},{"id":"OG002","title":"20060295: Conatumumab 3 mg/kg","description":"Conatumumab 3 mg/kg every 3 weeks by intravenous infusion."},{"id":"OG003","title":"20060340: Conatumumab 5 mg/kg","description":"Conatumumab 5 mg/kg once every 3 weeks by intravenous infusion."},{"id":"OG004","title":"20060464: Conatumumab 2 mg/kg + mFOLFOX6 + Bevacizumab","description":"Conatumumab 2 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy and bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG005","title":"20060464: Conatumumab 10 mg/kg + mFOLFOX6 ± Bevacizumab","description":"Conatumumab 10 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy, with or without bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG006","title":"20070411: Conatumumab 15 mg/kg + Ganitumab 18 mg/kg","description":"Conatumumab 15 mg/kg + ganitumab 18 mg/kg once every 3 weeks by intravenous infusion."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"}]}],"classes":[{"categories":[{"title":"Complete response","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"}]},{"title":"Partial response","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"1"},{"groupId":"OG006","value":"1"}]},{"title":"Stable disease","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"2"},{"groupId":"OG006","value":"1"}]},{"title":"Progressive disease","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Disease Progression or Death Due to Disease Progression","populationDescription":"Participants who received at least one dose of conatumumab or ganitumab.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From first dose of study drug in the extension study to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab.","groups":[{"id":"OG000","title":"20050118: Ganitumab 20 mg/kg","description":"Ganitumab 20 mg/kg once every 4 weeks by intravenous infusion."},{"id":"OG001","title":"20050171: Conatumumab 0.45 mg/kg","description":"Conatumumab 0.45 mg/kg every 2 weeks by intravenous infusion."},{"id":"OG002","title":"20060295: Conatumumab 3 mg/kg","description":"Conatumumab 3 mg/kg every 3 weeks by intravenous infusion."},{"id":"OG003","title":"20060340: Conatumumab 5 mg/kg","description":"Conatumumab 5 mg/kg once every 3 weeks by intravenous infusion."},{"id":"OG004","title":"20060464: Conatumumab 2 mg/kg + mFOLFOX6 + Bevacizumab","description":"Conatumumab 2 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy and bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG005","title":"20060464: Conatumumab 10 mg/kg + mFOLFOX6 ± Bevacizumab","description":"Conatumumab 10 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy, with or without bevacizumab 5 mg/kg once every 2 weeks."},{"id":"OG006","title":"20070411: Conatumumab 15 mg/kg + Ganitumab 18 mg/kg","description":"Conatumumab 15 mg/kg + ganitumab 18 mg/kg once every 3 weeks by intravenous infusion."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"2"}]}],"classes":[{"title":"Disease progression","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"2"},{"groupId":"OG006","value":"2"}]}]},{"title":"Death due to disease progression","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"From first dose of study drug in the extension study to 30 days after last dose; median duration of treatment with conatumumab was 1190.5 days and 1163.0 days for ganitumab.","eventGroups":[{"id":"EG000","title":"20050118: Ganitumab 20 mg/kg","description":"Ganitumab 20 mg/kg once every 4 weeks by intravenous infusion.","deathsNumAffected":0,"deathsNumAtRisk":2,"seriousNumAffected":1,"seriousNumAtRisk":2,"otherNumAffected":2,"otherNumAtRisk":2},{"id":"EG001","title":"20050171: Conatumumab 0.45 mg/kg","description":"Conatumumab 0.45 mg/kg every 2 weeks by intravenous infusion.","deathsNumAffected":0,"deathsNumAtRisk":1,"seriousNumAffected":0,"seriousNumAtRisk":1,"otherNumAffected":1,"otherNumAtRisk":1},{"id":"EG002","title":"20060295: Conatumumab 3 mg/kg","description":"Conatumumab 3 mg/kg every 3 weeks by intravenous infusion.","deathsNumAffected":0,"deathsNumAtRisk":1,"seriousNumAffected":1,"seriousNumAtRisk":1,"otherNumAffected":1,"otherNumAtRisk":1},{"id":"EG003","title":"20060340: Conatumumab 5 mg/kg","description":"Conatumumab 5 mg/kg once every 3 weeks by intravenous infusion.","deathsNumAffected":0,"deathsNumAtRisk":1,"seriousNumAffected":0,"seriousNumAtRisk":1,"otherNumAffected":1,"otherNumAtRisk":1},{"id":"EG004","title":"20060464: Conatumumab 2 mg/kg + mFOLFOX6 + Bevacizumab","description":"Conatumumab 2 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy and bevacizumab 5 mg/kg once every 2 weeks.","deathsNumAffected":1,"deathsNumAtRisk":2,"seriousNumAffected":1,"seriousNumAtRisk":2,"otherNumAffected":2,"otherNumAtRisk":2},{"id":"EG005","title":"20060464: Conatumumab 10 mg/kg + mFOLFOX6 ± Bevacizumab","description":"Conatumumab 10 mg/kg once every 2 weeks by intravenous infusion in addition to modified FOLFOX6 chemotherapy, with or without bevacizumab 5 mg/kg once every 2 weeks.","deathsNumAffected":0,"deathsNumAtRisk":3,"seriousNumAffected":3,"seriousNumAtRisk":3,"otherNumAffected":3,"otherNumAtRisk":3},{"id":"EG006","title":"20070411: Conatumumab 15 mg/kg + Ganitumab 18 mg/kg","description":"Conatumumab 15 mg/kg + ganitumab 18 mg/kg once every 3 weeks by intravenous infusion.","deathsNumAffected":0,"deathsNumAtRisk":2,"seriousNumAffected":2,"seriousNumAtRisk":2,"otherNumAffected":2,"otherNumAtRisk":2}],"seriousEvents":[{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Diverticular perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Abdominal wall abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hepatitis C","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Lumbar spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Rectal cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Transurethral bladder resection","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]}],"otherEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":2,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Leukopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Lymphopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":2,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Splenomegaly","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Cardiac flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Cardiomegaly","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Periorbital oedema","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":2,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Abdominal pain lower","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":2,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Dry mouth","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Dysphagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Haematochezia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Lip pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Lip swelling","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Loose tooth","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Oral pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Tooth loss","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Toothache","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Catheter site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Chills","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":2,"numAtRisk":2},{"groupId":"EG005","numAffected":2,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Gait disturbance","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"General physical health deterioration","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Injection site bruising","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Mucosal inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Oedema peripheral","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Peripheral swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":2,"numAtRisk":2},{"groupId":"EG005","numAffected":2,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Systemic inflammatory response syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Temperature intolerance","organSystem":"General disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hyperbilirubinaemia","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Abdominal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Abdominal wall abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Anal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Conjunctivitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Cystitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Eyelid infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Furuncle","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hepatitis C","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Herpes zoster","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":1,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Peritonitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Postoperative wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Tooth infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":1,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Vaginal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Vulvovaginal mycotic infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Eye contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Eyelid injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Fibula fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Ligament sprain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Tooth fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Wound complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Amylase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":2,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Anticoagulation drug level above therapeutic","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Aspartate aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Blood alkaline phosphatase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Blood creatinine increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":2,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Blood magnesium increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Blood phosphorus increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Blood testosterone decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Blood urea increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Blood uric acid increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Chest X-ray abnormal","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":1,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hepatic enzyme increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"International normalised ratio increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Weight decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"White blood cell count increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"White blood cells urine","organSystem":"Investigations","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":2,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":2,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Dyslipidaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hypercholesterolaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Hyperkalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Hyperlipidaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hyperuricaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hypoalbuminaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Hypocalcaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Hypomagnesaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Hypophosphataemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":2}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Bone pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Flank pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Groin pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Intervertebral disc degeneration","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Joint effusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Muscular weakness","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Musculoskeletal pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":1,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Basal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Lipoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Oesophageal carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Squamous cell carcinoma of skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Transitional cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Hypoaesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Neuropathy peripheral","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Paraesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Tremor","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Device occlusion","organSystem":"Product Issues","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Libido decreased","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Dysuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Nocturia","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Erectile dysfunction","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Genital rash","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Nipple pain","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Prostatomegaly","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Vaginal odour","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Vulvovaginal pruritus","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Allergic bronchitis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":1,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Dry throat","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Dysphonia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Lung infiltration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Pleuritic pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Productive cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Pulmonary congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":2,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Sleep apnoea syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Wheezing","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Acne","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Dry skin","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Eczema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Palmar-plantar erythrodysaesthesia syndrome","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Pruritus","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":1,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Rash macular","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Skin hypopigmentation","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Skin lesion","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":1,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":2}]},{"term":"Micrographic skin surgery","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Skin neoplasm excision","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":1,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Tooth extraction","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":2,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hot flush","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":1,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":0,"numAtRisk":2},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"May-Thurner syndrome","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]},{"term":"Peripheral venous disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 23.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":1},{"groupId":"EG003","numAffected":0,"numAtRisk":1},{"groupId":"EG004","numAffected":1,"numAtRisk":2},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":2}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication."},"pointOfContact":{"title":"Study Director","organization":"Amgen Inc.","email":"medinfo@amgen.com","phone":"866-572-6436"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2017-04-11","uploadDate":"2021-02-03T16:34","filename":"Prot_000.pdf","size":3052628},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2010-12-10","uploadDate":"2021-02-03T16:34","filename":"SAP_001.pdf","size":294041}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2025-12-17"},"conditionBrowseModule":{"meshes":[{"id":"D002276","term":"Carcinoid Tumor"},{"id":"D015179","term":"Colorectal Neoplasms"},{"id":"D008223","term":"Lymphoma"},{"id":"D009362","term":"Neoplasm Metastasis"},{"id":"D002289","term":"Carcinoma, Non-Small-Cell Lung"},{"id":"D012509","term":"Sarcoma"}],"ancestors":[{"id":"D018358","term":"Neuroendocrine Tumors"},{"id":"D017599","term":"Neuroectodermal Tumors"},{"id":"D009373","term":"Neoplasms, Germ Cell and Embryonal"},{"id":"D009370","term":"Neoplasms by Histologic Type"},{"id":"D009369","term":"Neoplasms"},{"id":"D000230","term":"Adenocarcinoma"},{"id":"D002277","term":"Carcinoma"},{"id":"D009375","term":"Neoplasms, Glandular and Epithelial"},{"id":"D009380","term":"Neoplasms, Nerve Tissue"},{"id":"D007414","term":"Intestinal Neoplasms"},{"id":"D005770","term":"Gastrointestinal Neoplasms"},{"id":"D004067","term":"Digestive System Neoplasms"},{"id":"D009371","term":"Neoplasms by Site"},{"id":"D004066","term":"Digestive System Diseases"},{"id":"D005767","term":"Gastrointestinal Diseases"},{"id":"D003108","term":"Colonic Diseases"},{"id":"D007410","term":"Intestinal Diseases"},{"id":"D012002","term":"Rectal Diseases"},{"id":"D008232","term":"Lymphoproliferative Disorders"},{"id":"D008206","term":"Lymphatic Diseases"},{"id":"D006425","term":"Hemic and Lymphatic Diseases"},{"id":"D007160","term":"Immunoproliferative Disorders"},{"id":"D007154","term":"Immune System Diseases"},{"id":"D009385","term":"Neoplastic Processes"},{"id":"D010335","term":"Pathologic Processes"},{"id":"D013568","term":"Pathological Conditions, Signs and Symptoms"},{"id":"D002283","term":"Carcinoma, Bronchogenic"},{"id":"D001984","term":"Bronchial Neoplasms"},{"id":"D008175","term":"Lung Neoplasms"},{"id":"D012142","term":"Respiratory Tract Neoplasms"},{"id":"D013899","term":"Thoracic Neoplasms"},{"id":"D008171","term":"Lung Diseases"},{"id":"D012140","term":"Respiratory Tract Diseases"},{"id":"D018204","term":"Neoplasms, Connective and Soft Tissue"}]},"interventionBrowseModule":{"meshes":[{"id":"C554537","term":"conatumumab"},{"id":"C545764","term":"ganitumab"},{"id":"D000068258","term":"Bevacizumab"}],"ancestors":[{"id":"D061067","term":"Antibodies, Monoclonal, Humanized"},{"id":"D000911","term":"Antibodies, Monoclonal"},{"id":"D000906","term":"Antibodies"},{"id":"D007136","term":"Immunoglobulins"},{"id":"D007162","term":"Immunoproteins"},{"id":"D001798","term":"Blood Proteins"},{"id":"D011506","term":"Proteins"},{"id":"D000602","term":"Amino Acids, Peptides, and Proteins"},{"id":"D012712","term":"Serum Globulins"},{"id":"D005916","term":"Globulins"}]}},"hasResults":true}